MELANIE BROST: Open Payments
NPI 1477933612 · CLEMMONS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 51 payments from 12 companies in 2025. Trend: 2023 $1,199 · 2024 $1,021 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $283 |
| Alkermes, Inc. | 11 | $226 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Corium, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $26 |
Products named: VRAYLAR, ARISTADA, REXULTI, Auvelity, COBENFY, FANAPT, CAPLYTA, LYBALVI.
Industry payments across NC — which companies pay providers there.
